10 results on '"Serwanska-Swietek M"'
Search Results
2. Analysis of Distribution of Expanded- and Standard-Criteria Donors and Complications Among Polish Recipients by Kidney Donor Risk Index Value
- Author
-
Serwanska-Swietek, M., primary, Wszola, M., additional, Domagala, P., additional, Berman, A., additional, Bieniasz, M., additional, Kieszek, R., additional, Karpeta, E., additional, Gorski, L., additional, Kwapisz, M., additional, Ostaszewska, A., additional, Sobol, M., additional, Bednarska, K., additional, Gniewkiewicz, M., additional, Perkowska-Ptasinska, A., additional, Deborska-Materkowska, D., additional, Gozdowska, J., additional, Durlik, M., additional, Chmura, A., additional, and Kwiatkowski, A., additional
- Published
- 2018
- Full Text
- View/download PDF
3. Islets Allotransplantation Into Gastric Submucosa in a Patient with Portal Hypertension: 4-year Follow-up
- Author
-
Wszola, M., primary, Berman, A., additional, Ostaszewska, A., additional, Gorski, L., additional, Serwanska-Swietek, M., additional, Gozdowska, J., additional, Bednarska, K., additional, Krajewska, M., additional, Lipinska, A., additional, Chmura, A., additional, and Kwiatkowski, A., additional
- Published
- 2018
- Full Text
- View/download PDF
4. Renal Transplantation Using Kidneys Procured From Elderly Donors Older Than 70 Years
- Author
-
Jozwik, A., primary, Domagala, P., additional, Kieszek, R., additional, Wszola, M., additional, Serwanska-Swietek, M., additional, Karpeta, E., additional, Gorski, L., additional, Bieniasz, M., additional, Jonas, M., additional, Berman, A., additional, Paczek, L., additional, Durlik, M., additional, Chmura, A., additional, and Kwiatkowski, A., additional
- Published
- 2016
- Full Text
- View/download PDF
5. The Influence of Donor Dna Level in Blood of Simultaneous Pancreas-Kidney Allograft Recipients as a Diagnostic Factor for Rejection
- Author
-
Zagozda, M., primary, Serwanska-Swietek, M., additional, Sarnecka, A., additional, Rydzewski, A., additional, Olszewski, W. L., additional, and Durlik, M., additional
- Published
- 2012
- Full Text
- View/download PDF
6. Do We Need Insulin Independence After Islet Transplantation?
- Author
-
Berman A, Wszola M, Gorski L, Serwanska-Swietek M, Ostaszewska A, Lipinska A, Durlik M, Chmura A, and Kwiatkowski A
- Subjects
- Adult, Blood Glucose analysis, Diabetes Mellitus, Type 1 blood, Female, Humans, Male, Middle Aged, Diabetes Mellitus, Type 1 complications, Diabetes Mellitus, Type 1 surgery, Insulin blood, Insulin therapeutic use, Islets of Langerhans Transplantation
- Abstract
Introduction: Most life-threatening diabetes-related complications involve the kidneys, eyes, cardiovascular system, and autonomic nervous system. Clinical islet transplantation (CITx) may be a therapeutic option for some patients. In this study, we analyzed the progression of diabetic complications after CITx and in patients waiting for islet transplantation., Methods: From 2008 to 2015, 67 patients were listed for pancreatic or islet transplantation. We compared beta scores, islet scores, and secondary complications between patients who underwent islet allotransplantation (CITx group, n = 6) and the patients awaiting islet transplantation (wait group, n = 19) at baseline and during the 1-year follow-up., Results: In the CITx group, good islet function was observed in 80% of patients 1 month post-transplantation and 40% of patients 1 year post-transplantation; however, no patient achieved insulin independence. One patient who underwent simultaneous islet-kidney transplantation died on day 8 because of severe bleeding in the retroperitoneal space. In 1 case, islet primary nonfunction was observed. Mean islet score in the CITx group 1 year post-transplantation was significantly higher than the pretransplant score and wait group scores at enrollment and 1 year later (P < .01). Increased albuminuria was observed in 3 of 11 (27%) patients in the wait group and 0 patients in the CITx group (P = .08). One patient (9%) in the wait group developed chronic renal failure requiring hemodialysis. Ophthalmologic procedures were required by 47% of patients in the wait group and 0 patients in the CITx group in the first year after transplantation (P < .01)., Conclusion: Successful islet transplantation slows the progression of diabetic complications., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
7. Should Immunosuppression After Kidney Transplant Be Adjusted Based on Renal Resistance During Pretransplant Hypothermic Machine Perfusion?
- Author
-
Wszola M, Domagala P, Serwanska-Swietek M, Ostaszewska A, Perkowska-Ptasinska A, Piatek T, Gozdowska J, Durlik M, Chmura A, and Kwiatkowski A
- Subjects
- Adult, Delayed Graft Function physiopathology, Female, Graft Rejection physiopathology, Graft Survival, Humans, Male, Middle Aged, Perfusion, Immunosuppression Therapy methods, Kidney physiopathology, Kidney Transplantation, Organ Preservation methods, Transplants physiopathology
- Abstract
Background: The hypothermic machine perfusion reduces delayed graft function after kidney transplant and allows, to some extent, predicting early graft function. However, it is difficult to identify exact perfusion criteria with which to exclude kidneys from transplant or modify post-transplant care. The aim of this study was to analyze whether renal resistance during the fourth hour of hypothermic machine perfusion is useful in the prediction of graft survival and acute rejection., Patients and Methods: Data on pretransplant hypothermic machine perfusion parameters of 407 transplanted kidneys were available. Receiver operating characteristic curve analysis was performed to find an optimal cutoff value of ratio for predicting a higher risk class of considered group of patients. According to this, patients were divided into 2 groups: those who received kidneys with renal resistance lower than 0.19 mm Hg/mL/min (R1; n = 187) and those who received kidneys with renal resistance equal to or higher than 0.19 mm Hg/mL/min (R2; n = 220). Within R2, we additionally analyzed 2 subgroups: patients who received induction therapy (R2-Ind+; n = 124) and those who did not received induction therapy (R2-Ind-; n = 96)., Results: Acute rejection in R1 within 1 month post transplant was 2-fold lower compared with R2 and was 6.4% vs 13.1% (P = .03), respectively. One-year graft survival was higher in R1 compared with R2 and was 94.6% vs 88.5% (P = .03), respectively. Acute rejection in the R2-Ind+ subgroup within 1 month post transplant was 2.46-fold lower compared with the R2-Ind- subgroup and was 8% vs 19.7% (P = .01), respectively., Conclusion: Immunosuppression treatment after transplant should be adjusted to perfusion parameters., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
8. Reoperation in Early Kidney Post-transplant Period as a Strong Risk Factor of Surgical Site Infection Occurrence.
- Author
-
Ostaszewska A, Wszola M, Olszewska N, Karpeta E, Serwanska-Swietek M, Kuthan R, Kawecki D, Berman A, Domagała P, Kwiatkowski A, and Chmura A
- Subjects
- Adult, Aged, Antibiotic Prophylaxis methods, Female, Humans, Male, Middle Aged, Risk Factors, Surgical Wound Infection prevention & control, Kidney Transplantation adverse effects, Reoperation adverse effects, Surgical Wound Infection epidemiology
- Abstract
Background: One of the most common infective complications after kidney transplant (KTx) is surgical site infection (SSI). Providing indications of improvement of perioperative antibiotic prophylaxis (PAP) and allowing the characterization of risk factors are critical to reduce SSI. The purpose of this study was to evaluate the SSI risk factors and impact of reoperation in the early post-transplant period on SSI occurrence and assess if standard PAP in those cases is a best consideration., Methods: Between April 2014 and October 2015, a total of 236 KTxs were performed in our center. Deceased donor data, recipient data, and data related to surgical procedures were collected., Results: Surgical site infections were reported in 5.6% (12/214) of patients. Seven patients were diagnosed as having superficial SSI (7/12; 58.3%), 2 with deep SSI (2/12; 16.6%), and 4 with organ-specific SSI (4/12; 33.3%). Extended criteria donor-related transplant, cold ischemia time > 22 hours, dialysis period > 30 months, recipient age older than 45 years, recipient body mass index > 27, induction therapy prior to transplant, diabetes prior to transplant, and ≥ 1 reoperation during 30 days of observation were independent risk factors of SSI occurrence. A total of 19 reoperations were performed in 17 patients. In 8 of all 12 patients with SSI diagnosis, the reoperation was performed (66.7%). In 202 patients of non-SSI patients, only 9 reoperations were performed (4.5%)., Conclusions: Early reoperation after Ktx is a strong risk factor of SSI occurrence. There is a probability that > 4 SSI risk factors and reoperation in the early post-transplant period could require different and more aggressive proceeding, as standard PAP in those cases is insufficient., (Copyright © 2019. Published by Elsevier Inc.)
- Published
- 2019
- Full Text
- View/download PDF
9. Islet Autotransplantation in Diabetic Patients.
- Author
-
Berman A, Wszola M, Gorski L, Serwanska-Swietek M, Ostaszewska A, Lipinska A, Chmura A, and Kwiatkowski A
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Transplantation, Autologous, Diabetes Mellitus, Type 1 surgery, Islets of Langerhans Transplantation methods, Pancreatectomy methods, Pancreatitis, Chronic surgery
- Abstract
Introduction: Painful chronic pancreatitis (CP) is the main indication for analgesic pancreatectomy with simultaneous islet autotransplantation to prevent postoperative diabetes mellitus (DM). However, advanced CP may lead to insulin secretion disorders and DM. There are doubts as to whether islet autotransplantation in such cases is an appropriate procedure. The aim of this study was to analyze the results of islet autotransplantation in patients with CP with already diagnosed with DM., Method: Between 2008 and 2015, at the Department of General and Transplantation Surgery, patients with CP and unsatisfying pain treatment with positive fasting C-peptide ( > 0.3 ng/mL) level were qualified for simultaneous pancreatectomy and islet autotransplantation. Eight procedures were performed. In 5 cases patients had DM diagnosed prior to the procedure (DM group n = 5). Three patients without DM diagnosed prior to surgery were the control group (n = 3)., Result: There were no cases of procedure-related deaths in either group. Pain relief without analgesics was reported by all patients. Good islet function was observed in 80% (4/5) of the DM group vs 100% (3/3) in the control group (P = ns). Brittle diabetes was diagnosed in 1 patient in the DM group as a result of islet primary non-function., Conclusion: Patients with CP-related severe pain and DM patients with positive C-peptides should be considered for pancreatectomy and islet autotransplantation., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
10. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
- Author
-
Deborska-Materkowska D, Perkowska-Ptasinska A, Sadowska A, Gozdowska J, Ciszek M, Serwanska-Swietek M, Domagala P, Miszewska-Szyszkowska D, Sitarek E, Jozwik A, Kwiatkowski A, and Durlik M
- Subjects
- Adult, Aged, Antibodies, Viral blood, Antiviral Agents therapeutic use, Cytomegalovirus genetics, Cytomegalovirus Infections epidemiology, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prospective Studies, T-Lymphocytes immunology, T-Lymphocytes virology, Tissue Donors, Transplant Recipients, Viremia diagnosis, Viremia drug therapy, Cytomegalovirus immunology, Cytomegalovirus Infections diagnosis, Cytomegalovirus Infections prevention & control, Kidney Transplantation adverse effects, Valganciclovir therapeutic use
- Abstract
Background: Despite universal prophylaxis, late cytomegalovirus (CMV) infection occurs in a high proportion of kidney transplant recipients. We evaluated whether a specific viral T-cell response allows for the better identification of recipients who are at high risk of CMV infection after prophylaxis withdrawal., Methods: We conducted a prospective study in 19 pretransplant anti-CMV seronegative kidney graft recipients R- (18 from seropositive donors [D+] and one from a seronegative donor [D-]) and 67 seropositive recipients R(+) (59 from seropositive donors and eight from seronegative donors) who received antiviral prophylaxis with valganciclovir. The QuantiFERON-CMV (QF-CMV) assay was performed within the first and third months after transplantation. Blood samples were monitored for CMV DNAemia using a commercial quantitative nucleic acid amplification test (QNAT) that was calibrated to the World Health Organization International Standard., Results: Twenty-one of the 86 patients (24%) developed CMV viremia after prophylaxis withdrawal within 12 months posttransplantation. In the CMV R(+) group, the QF-CMV assay yielded reactive results (QF-CMV[+]) in 51 of 67 patients (76%) compared with 7 of 19 patients (37%) in the CMV R(-) group (p = 0.001). In the CMV R(+) group, infection occurred in seven of 16 recipients (44%) who were QF-CMV(-) and eight of 51 recipients (16%) who were QF-CMV(+). In the CMV R(-) group, infection evolved in five of 12 recipients (42%) who were QF-CMV(-) and one of 7 recipients (14%) who were QF-CMV(+). No difference was found in the incidence of CMV infection stratified according to the QF-CMV results with regard to the recipients' pretransplant CMV IgG serology (p = 0.985). Cytomegalovirus infection occurred in 15 of 36 patients (42%) with hypogammaglobulinemia (HGG) 90 days posttransplantation compared with two of 34 patients (6%) without HGG (p = 0.0004). Cytomegalovirus infection occurred in seven of 13 patients (54%) with lymphocytopenia compared with 14 of 70 patients (20%) without lymphocytopenia (p = 0.015). The multivariate analysis revealed that the nonreactive QuantiFERON-CMV assay was an independent risk factor for postprophylaxis CMV infection., Conclusions: In kidney transplant recipients who received posttransplantation prophylaxis, negative QF-CMV results better defined the risk of CMV infection than initial CMV IgG status after prophylaxis withdrawal. Hypogammaglobulinemia and lymphocytopenia were risk factors for CMV infection.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.